Edition:
India

People: Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

100.60USD
16 Aug 2019
Change (% chg)

$0.71 (+0.71%)
Prev Close
$99.89
Open
$100.69
Day's High
$101.05
Day's Low
$100.31
Volume
253,059
Avg. Vol
245,034
52-wk High
$112.34
52-wk Low
$78.97

Guinan, Mark 

Mr. Mark J. Guinan is Chief Financial Officer, Executive Vice President of the Company. Mr. Guinan joined the Company in July 2013. From 2010 until joining Quest Diagnostics in 2013, he served as Chief Financial Officer for Hill-Rom Holdings Inc., a manufacturer and provider of medical technologies and related services for the health care industry. Mr. Guinan has served as a director of Myovant Sciences, Ltd. since July 2018. Previously, he had served in a number of finance and operations roles in a long career at Johnson & Johnson including 2009 to 2010 as Vice President, Chief Procurement Officer, and 2005 to 2009 as Vice President, Group Finance Pharmaceuticals. Before joining Johnson & Johnson in 1997, he held a number of financial roles at Procter & Gamble.

Basic Compensation

Total Annual Compensation, USD 876,823
Restricted Stock Award, USD 1,380,070
Long-Term Incentive Plans, USD --
All Other, USD 976,391
Fiscal Year Total, USD 3,233,280

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --